Our analysis reveals that, regardless of the tumour stage, TGF-β exerts a potent suppressor effect on iCCA tumour cells that is dependent on a functional SMAD2/3/4 complex and that inhibition of TGF-β receptors boosts iCCA progression by promoting tumour cell growth. Here, TGFB1 is linked to neoplasm.